242 related articles for article (PubMed ID: 11420707)
1. Loss of p53 tumor suppressor function is required for in vivo progression of Friend erythroleukemia.
Prasher JM; Elenitoba-Johnson KS; Kelley LL
Oncogene; 2001 May; 20(23):2946-55. PubMed ID: 11420707
[TBL] [Abstract][Full Text] [Related]
2. Loss of p53 in F-MuLV induced-erythroleukemias accelerates the acquisition of mutational events that confers immortality and growth factor independence.
Wong KS; Li YJ; Howard J; Ben-David Y
Oncogene; 1999 Sep; 18(40):5525-34. PubMed ID: 10523829
[TBL] [Abstract][Full Text] [Related]
3. p53 transgenic mice: accelerated erythroleukemia induction by Friend virus.
Lavigueur A; Bernstein A
Oncogene; 1991 Dec; 6(12):2197-201. PubMed ID: 1766668
[TBL] [Abstract][Full Text] [Related]
4. Endogenous p53 regulation and function in early stage Friend virus-induced tumor progression differs from that following DNA damage.
Kelley LL; Hicks GG; Hsieh FF; Prasher JM; Green WF; Miller MD; Eide EJ; Ruley HE
Oncogene; 1998 Sep; 17(9):1119-30. PubMed ID: 9764822
[TBL] [Abstract][Full Text] [Related]
5. Bcl-2 expression in F-MuLV-induced erythroleukemias: a role for the anti-apoptotic action of Bcl-2 during tumor progression.
Howard JC; Li Q; Chu W; Zochodne B; Kapoor M; Ung Y; Rosen K; Ben-David Y
Oncogene; 2001 Apr; 20(18):2291-300. PubMed ID: 11402324
[TBL] [Abstract][Full Text] [Related]
6. Insertional inactivation of the p53 gene during friend leukemia: a new strategy for identifying tumor suppressor genes.
Ben-David Y; Lavigueur A; Cheong GY; Bernstein A
New Biol; 1990 Nov; 2(11):1015-23. PubMed ID: 2101628
[TBL] [Abstract][Full Text] [Related]
7. Inactivation of the p53 oncogene by internal deletion or retroviral integration in erythroleukemic cell lines induced by Friend leukemia virus.
Ben David Y; Prideaux VR; Chow V; Benchimol S; Bernstein A
Oncogene; 1988 Aug; 3(2):179-85. PubMed ID: 2842714
[TBL] [Abstract][Full Text] [Related]
8. Friend virus-induced erythroleukemias: a unique and well-defined mouse model for the development of leukemia.
Lee CR; Cervi D; Truong AH; Li YJ; Sarkar A; Ben-David Y
Anticancer Res; 2003; 23(3A):2159-66. PubMed ID: 12894591
[TBL] [Abstract][Full Text] [Related]
9. p53-independent tumor growth and in vitro cell survival for F-MuLV-induced erythroleukemias.
Howard J; Ung Y; Adachi D; Ben-David Y
Cell Growth Differ; 1996 Dec; 7(12):1651-60. PubMed ID: 8959333
[TBL] [Abstract][Full Text] [Related]
10. Friend virus induced murine erythroleukaemia: the p53 locus.
Johnson P; Benchimol S
Cancer Surv; 1992; 12():137-51. PubMed ID: 1638545
[TBL] [Abstract][Full Text] [Related]
11. Spi-1 transgenic mice develop a clonal erythroleukemia which does not depend on p53 mutation.
Barnache S; Wendling F; Lacombe C; Denis N; Titeux M; Vainchenker W; Moreau-Gachelin F
Oncogene; 1998 Jun; 16(23):2989-95. PubMed ID: 9662331
[TBL] [Abstract][Full Text] [Related]
12. Selection for loss of p53 function in T-cell lymphomagenesis is alleviated by Moloney murine leukemia virus infection in myc transgenic mice.
Baxter EW; Blyth K; Cameron ER; Neil JC
J Virol; 2001 Oct; 75(20):9790-8. PubMed ID: 11559812
[TBL] [Abstract][Full Text] [Related]
13. Temporal order and functional analysis of mutations within the Fli-1 and p53 genes during the erythroleukemias induced by F-MuLV.
Howard JC; Yousefi S; Cheong G; Bernstein A; Ben-David Y
Oncogene; 1993 Oct; 8(10):2721-9. PubMed ID: 8378083
[TBL] [Abstract][Full Text] [Related]
14. Activation of the erythropoietin gene in the majority of F-MuLV-induced erythroleukemias results in growth factor independence and enhanced tumorigenicity.
Howard JC; Berger L; Bani MR; Hawley RG; Ben-David Y
Oncogene; 1996 Apr; 12(7):1405-15. PubMed ID: 8622856
[TBL] [Abstract][Full Text] [Related]
15. Mutation of the Lyn tyrosine kinase delays the progression of Friend virus induced erythroleukemia without affecting susceptibility.
Subramanian A; Hegde S; Correll PH; Paulson RF
Leuk Res; 2006 Sep; 30(9):1141-9. PubMed ID: 16527351
[TBL] [Abstract][Full Text] [Related]
16. Loss of a highly conserved domain on p53 as a result of gene deletion during Friend virus-induced erythroleukemia.
Munroe DG; Rovinski B; Bernstein A; Benchimol S
Oncogene; 1988 Jun; 2(6):621-4. PubMed ID: 3290808
[TBL] [Abstract][Full Text] [Related]
17. Pathogenesis of Friend leukemia virus.
Ikawa Y
Leukemia; 1997 Apr; 11 Suppl 3():152-4. PubMed ID: 9209327
[TBL] [Abstract][Full Text] [Related]
18. Self-renewal of leukemia stem cells in Friend virus-induced erythroleukemia requires proviral insertional activation of Spi1 and hedgehog signaling but not mutation of p53.
Hegde S; Hankey P; Paulson RF
Stem Cells; 2012 Feb; 30(2):121-30. PubMed ID: 22083997
[TBL] [Abstract][Full Text] [Related]
19. Phosphorylation status of c-Kit and Epo receptors, and the presence of wild-type p53 confer in vitro resistance of murine erythroleukemic cells to Celecoxib.
Cervi D; Truong AH; Lee JS; Sukhai N; Li YJ; Koki A; Ben-David Y
Oncogene; 2004 Mar; 23(13):2305-14. PubMed ID: 14743207
[TBL] [Abstract][Full Text] [Related]
20. Exogenous wild-type p53 gene improved survival of nude mice injected with murine erythroleukemia cell line through amelioration of hemorheological changes.
Zhang Y; Yao W; Zeng Z; Wang X; Sun D; Ka W; Zhou S; He D; Wen Z; Chien S
Microcirculation; 2007 Feb; 14(2):155-66. PubMed ID: 17365670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
